Why did APM surge?

Aptorum Group's (APM) recent surge of 100.04% on July 16, 2025, can be attributed to **Strategic Merger with DiamiR Biosciences**.

The company's announcement of a definitive merger agreement with DiamiR Biosciences has been a pivotal moment for APM. This merger is a bold strategic shift that capitalizes on the diagnostic tools market, particularly in neurodegenerative diseases. The all-stock deal sees DiamiR shareholders taking 70% of the combined entity, targeting brain health diagnostics. The merger transforms APM into a diagnostics-driven company, leveraging DiamiR’s CLIA-certified lab and microRNA testing tech. This transformative potential has fueled a significant surge in the stock's value.

|code|Ticker|Name|Date|Percentage Change|market_code|
|---|---|---|---|---|---|
|APM|APM.O|Aptorum Group|20250717|2.567010309278354|186|